Clinical Trial Applications: Filter, Search, and view applications
| # | Protocol No | Study Title | Investigator(s) & Site(s) | |
|---|---|---|---|---|
341. |
ECCT/24/08/06 | KALUMA Study A randomized, open-label, multicenter study to compare efficacy, safety and tolerability of KLU156 with Coartem® in the treatment of uncomplicated Plasmodium falciparum malaria in adults and children ≥ 5 kg body weight followed by an Extension phase with repeated KLU156 treatment |
Principal Investigator(s) 1. Dr Patricia Odera Ojwang 2. Dr. Bernhards Ogutu 3. Dr.Bernhards Ogutu Site(s) in Kenya 1. Site 1600: Kenya Medical Research Institute/Centre for Global Health Research Siaya (Siaya county) 2. Site 1601:Kombewa Clinical Research Centre (Kisumu county) 3. Ahero Clinical Trial Unit (Kisumu county) |
View |
342. |
ECCT/17/05/04 | Ad26.Mos4.HIV Prime/Ad26.Mos4.HIV with Clade C gp140 plus adjuvant +/- Mosaic boost A randomized, parallel-group, placebo-controlled, double-blind Phase 1/2a study in healthy HIV-uninfected adults to assess safety/tolerability and immunogenicity of 2 different prime/boost regimens: priming with tetravalent Ad26.Mos4.HIV and boosting with tetravalent Ad26.Mos4.HIV and either Clade C gp140 plus adjuvant OR a combination of Mosaic and Clade C gp140 plus adjuvant |
Principal Investigator(s) 1. Josphat Kosgei Site(s) in Kenya KEMRI WALTER REED KERICHO |
View |
343. |
ECCT/24/08/01 | Evaluate clearance of HPV A Randomized, Placebo-Controlled Study to Evaluate Clearance of High-Risk Human Papillomavirus and Safety After Administration of ABI-2280 Vaginal Inserts |
Principal Investigator(s) 1. Fredrick Chite Asirwa 2. Kevin Makori Gesimba Site(s) in Kenya 1. International Cancer Institute (ICI) (Uasin Gishu county) 2. Victoria Cancer Care and Research centre (Nyamira county) |
View |
344. |
ECCT/19/10/01 | AMC-099 A Randomized, Placebo-Controlled Trial of HPV Vaccination to Reduce Cervical High-Grade Squamous Intraepithelial Lesions among HIV-Infected Women Participating in an HPV Test-and-Treat Program (COVENANT) |
Principal Investigator(s) 1. ELKANAH ORANGO OMENGE Site(s) in Kenya MOI UNIVERSITY CLINICAL RESEARCH CENTER |
View |
345. |
ECCT/23/06/09 | Hibiscus Kid\'s Study A Single Arm, Open Label, Phase 1/2 Study to Evaluate the Pharmacokinetics and Safety of Etavopivat in Pediatric Patients with Sickle Cell Disease |
Principal Investigator(s) 1. Walter Otieno 2. Videlis Nduba Site(s) in Kenya 1. Kombewa Clinical research Centre (Kisumu county) 2. KEMRI, Siaya Clinical Research Annex (Kisumu county) |
View |